Cipla US arm recalls Vigabatrin for Oral Solution, USP 500mg over pouch leakage issues Ruchika Sharma11 Dec 2023 3:00 PM ISTCipla has not received any reports of adverse events related to this recall.
submit pool data along with Indian patient data: CDSCO panel Tells MSN Laboratories Over Vigabatrin Tablets Dr. Divya Colin30 Aug 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major MSN Laboratories to manufacture and market the antiepileptic drug Vigabatrin, the...
MSN Lab Gets CDSCO Panel Nod To Manufacture, Market Vigabatrin Powder for Oral Solution Dr. Divya Colin28 Jun 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
USFDA approves Zydus Lifesciences Infantile spasm drug Vigabatrin Ruchika Sharma4 March 2023 11:10 AM ISTThe drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad.
Granules India gets USFDA nod for Vigabatrin for Oral Solution Ruchika Sharma27 April 2020 1:01 PM ISTHyderabad: Granules India Limited has announced that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application...
